Experience of the use of drugs with thioctic acid in overweight women using combined oral contraceptives

Authors

  • N. V. Avramenko Zaporozhye State Medical University,
  • I. B. Gridina Zaporozhye State Medical University,
  • O. A. Nikiforov Zaporozhye State Medical University,
  • E. A. Lomeyko Zaporozhye State Medical University,

DOI:

https://doi.org/10.14739/2310-1210.2014.1.23642

Keywords:

overweight, contraception, thioctic acid

Abstract

Introduction

Overweight is a serious medical, social and economic problem of the modern society. Today it is established that the level of sexual activity in women is not dependent on the body mass index. Unfortunately, about 40% of patients with overweight stop to receive modern combined oral contraceptives in the first two months of the side effects occurrence. Today it is very important to improve the modern combined oral contraceptives intake by women with overweight.

Research objective

To compare tolerance to the modern combined oral contraceptives with thioctic acid in women with excessive body weight.

Materials and methods

64 patients were divided into two groups. Patients of the 1 group (32 observations) were recommended to use thioctic acid in a dose of 600 mg daily for the first month of reception of a modern combined oral contraceptive containing etinilestradiol and desogestrel. Women of the control group (32 observations) used combined oral contraceptives containing levonorgestrel and desogestrel, but not used drugs with thioctic acid.

The results of the research

In the course of the observation spotting were noted in 40% of women in both groups. The nausea was observed in 20% of patients of the second group and only in 7% of the patients in the first group. Decreased libido, and mood were observed only in 5% of patients of the first group and in 15% of patients of the second group. Weight gain within2 kgdue to fluid retention was observed in 30% of patients of the second group and only in 10% of the patients of the first group. After the end of the observation 90% of women of the first group and 75% of women of the second group continued to take combined oral contraceptive.

Conclusions

Use of thioctic acid in a daily dose 600 mg for the first month of intake of the combined oral  contraceptive can significantly reduce the frequency of such unpleasant side effects as nausea, decreased libido, and mood, increased body mass index.

References

Метаболический сердечно-сосудистый синдром / [В.А. Алмазов, Я.В. Благосклонная, Е.В. Шляхто, Е.И. Красильникова]. – СПб.: ГМУ, 1999. – 203 с.

Дедов И.И. Патогенетические аспекты ожирения / И.И. Дедов, Г.А. Мельниченко, Т.И. Романцова // Ожирение и метаболизм. – 2004. – № 1. – С. 3–9.

Критерии приемлемости использования методов контрацепции / Всемирная организация здравоохранения, 2004.

Прилепская В.Н. Гинекологическая эндокринология / В.Н. Прилепская, Е.В. Цаллагова. – М., 2004. – С. 283–320.

Лептин и липидный спектр крови у женщин с разными типами ожирения / А.В. Светлаков, М.В. Яманова, О.С. Филиппов, Н.А. Малахова // Пробл. репродук. – 2001. – №6. – С. 33–35.

Фармацевтична опіка при використанні засобів контрацепції: навчальний посібник / [Ю.П. Вдовиченко, Г.М. Войтенко, І.М. Білай та ін..]. – К.: Книга плюс, 2010. – 176 с.

Huang K.C. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents / Huang KC, Lin RC, Kormas N et al. // International Journal of Obesity. – 2004. – Vol. 12. – P. 23–25.

Roberts L. Obesity. About the size of it / Roberts L., Haycox A. // Health Serv J. – 1999. – Vol. 109 (5662). – Р. 28–29.

How to Cite

1.
Avramenko NV, Gridina IB, Nikiforov OA, Lomeyko EA. Experience of the use of drugs with thioctic acid in overweight women using combined oral contraceptives. Zaporozhye Medical Journal [Internet]. 2014Apr.22 [cited 2024Nov.12];16(1). Available from: http://zmj.zsmu.edu.ua/article/view/23642

Issue

Section

Original research